Public Profile

A. Nattermann & Cie. Gesellschaft Mit Beschränkter Haftung

A. Nattermann & Cie. Gesellschaft Mit Beschränkter Haftung, commonly referred to as Nattermann, is a distinguished player in the pharmaceutical and biotechnology industry, headquartered in Germany. Founded in the early 20th century, the company has established a strong presence in Europe and beyond, focusing on the development and production of high-quality active pharmaceutical ingredients (APIs) and intermediates. Nattermann is renowned for its commitment to innovation and quality, offering a diverse range of products that cater to various therapeutic areas. The company has achieved significant milestones, including strategic partnerships and expansions that have solidified its market position. With a reputation for excellence, A. Nattermann & Cie. continues to contribute to advancements in healthcare, making it a trusted name in the pharmaceutical landscape.

DitchCarbon Score

How does A. Nattermann & Cie. Gesellschaft Mit Beschränkter Haftung's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

52

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

A. Nattermann & Cie. Gesellschaft Mit Beschränkter Haftung's score of 52 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

A. Nattermann & Cie. Gesellschaft Mit Beschränkter Haftung's reported carbon emissions

A. Nattermann & Cie. Gesellschaft Mit Beschränkter Haftung, headquartered in Germany, currently does not have available carbon emissions data for the most recent year. As such, specific figures regarding their Scope 1, 2, or 3 emissions are not provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting practices. In the context of the industry, it is increasingly important for companies to establish clear emissions reduction strategies and targets to align with global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. A. Nattermann & Cie. Gesellschaft Mit Beschränkter Haftung's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for A. Nattermann & Cie. Gesellschaft Mit Beschränkter Haftung is in DE, which has a medium grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

A. Nattermann & Cie. Gesellschaft Mit Beschränkter Haftung is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Rockwell Medical, Inc.

US
Health and social work services (85)
Updated 2 days ago

Vifor (International) AG

CH
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Shield Therapeutics plc

GB
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

AMAG Pharmaceuticals, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers